# RenovoRx, Inc. (RNXT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RNXT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 563.0K | $ -3.52M | $ -3.64M | $ 78.0K | $ 11.27M |
| 2025 | $ 1.15M | $ -11.44M | $ -11.24M | $ 107.0K | $ 5.42M |
| 2024 | $ 45.2K | $ -9.26M | $ -9.60M | $ 278.0K | $ 4.48M |
| 2023 | $ 0 | $ -11.06M | $ -11.09M | $ 0 | $ -3.00M |
| 2022 | $ 0 | $ -11.05M | $ -9.84M | $ 0 | $ 6.16M |
| 2021 | $ 0 | $ -7.52M | $ -7.05M | $ 0 | $ 15.35M |
| 2020 | $ 0 | $ -4.84M | $ -4.49M | $ 2.79M | $ -14.66M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.24 |
| Current Ratio | 7.15 |

## Other views

- [Metrics](https://sponda.capital/en/RNXT.md)
- [Charts](https://sponda.capital/en/RNXT/charts.md)
- [Compare](https://sponda.capital/en/RNXT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.